(DXC) DXC Technology - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US23355L1061
Stock: Consulting, Analytics, Software, Cloud, Security
Total Rating 30
Risk 62
Buy Signal -0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 44.6% |
| Relative Tail Risk | -2.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.56 |
| Alpha | -51.67 |
| Character TTM | |
|---|---|
| Beta | 1.483 |
| Beta Downside | 1.582 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.41% |
| CAGR/Max DD | -0.35 |
EPS (Earnings per Share)
Revenue
Description: DXC DXC Technology March 03, 2026
DXC Technology (NYSE:DXC) delivers end-to-end IT services through two main segments: Global Business Services (GBS), which focuses on analytics, software engineering, consulting, and industry-specific solutions such as insurance platforms and banking-card processing; and Global Infrastructure Services (GIS), which provides cloud migration, security (including zero-trust and SOC operations), and managed IT outsourcing. The company serves commercial and public-sector clients across the U.S., U.K., Europe, Australia and other regions, leveraging a direct sales force and an extensive partner ecosystem.
Recent performance highlights include FY 2025 Q4 revenue of $4.2 billion, a 3.1% YoY increase driven by higher demand for hybrid-cloud and cybersecurity services, and an adjusted EBITDA margin of 9.4%, up from 8.7% in the prior quarter. Enterprise IT spending is projected to grow 5.2% annually through 2027, with cloud-infrastructure and security budgets outpacing the broader market, providing tailwinds for DXC’s GIS segment.
For a deeper dive into DXC’s valuation and outlook, you might explore the analysis on ValueRay.
Headlines to watch out for
- Global Business Services revenue growth drives stock performance
- Cloud infrastructure demand impacts GIS segment sales
- Cybersecurity services adoption boosts revenue
- IT outsourcing contract renewals stabilize income
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 423.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.72 > 1.0 |
| NWC/Revenue: 10.73% < 20% (prev 9.96%; Δ 0.77% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.32b > Net Income 423.0m |
| Net Debt (3.06b) to EBITDA (2.13b): 1.44 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (180.2m) vs 12m ago -2.49% < -2% |
| Gross Margin: 19.70% > 18% (prev 0.24%; Δ 1945 % > 0.5%) |
| Asset Turnover: 96.78% > 50% (prev 99.19%; Δ -2.41% > 0%) |
| Interest Coverage Ratio: 4.23 > 6 (EBITDA TTM 2.13b / Interest Expense TTM 219.0m) |
Altman Z'' 0.02
| A: 0.10 (Total Current Assets 5.27b - Total Current Liabilities 3.91b) / Total Assets 13.18b |
| B: -0.22 (Retained Earnings -2.93b / Total Assets 13.18b) |
| C: 0.07 (EBIT TTM 926.0m / Avg Total Assets 13.11b) |
| D: -0.39 (Book Value of Equity -3.80b / Total Liabilities 9.76b) |
| Altman-Z'' Score: 0.02 = B |
Beneish M -2.84
| DSRI: 1.07 (Receivables 2.91b/2.76b, Revenue 12.68b/12.93b) |
| GMI: 1.23 (GM 19.70% / 24.31%) |
| AQI: 1.00 (AQ_t 0.46 / AQ_t-1 0.46) |
| SGI: 0.98 (Revenue 12.68b / 12.93b) |
| TATA: -0.07 (NI 423.0m - CFO 1.32b) / TA 13.18b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of DXC shares?
As of March 09, 2026, the stock is trading at USD 12.95 with a total of 1,568,461 shares traded.
Over the past week, the price has changed by +6.23%, over one month by -9.57%, over three months by -9.82% and over the past year by -27.04%.
Over the past week, the price has changed by +6.23%, over one month by -9.57%, over three months by -9.82% and over the past year by -27.04%.
Is DXC a buy, sell or hold?
DXC Technology has received a consensus analysts rating of 2.70.
Therefor, it is recommend to hold DXC.
- StrongBuy: 0
- Buy: 0
- Hold: 8
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the DXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.8 | 13.9% |
| Analysts Target Price | 14.8 | 13.9% |
DXC Fundamental Data Overview March 05, 2026
P/E Trailing = 5.3609
P/E Forward = 3.639
P/S = 0.1693
P/B = 0.658
P/EG = 0.28
Revenue TTM = 12.68b USD
EBIT TTM = 926.0m USD
EBITDA TTM = 2.13b USD
Long Term Debt = 2.99b USD (from longTermDebt, last quarter)
Short Term Debt = 765.0m USD (from shortTermDebt, last quarter)
Debt = 4.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.06b USD (from netDebt column, last quarter)
Enterprise Value = 5.21b USD (2.15b + Debt 4.79b - CCE 1.73b)
Interest Coverage Ratio = 4.23 (Ebit TTM 926.0m / Interest Expense TTM 219.0m)
EV/FCF = 4.71x (Enterprise Value 5.21b / FCF TTM 1.10b)
FCF Yield = 21.23% (FCF TTM 1.10b / Enterprise Value 5.21b)
FCF Margin = 8.71% (FCF TTM 1.10b / Revenue TTM 12.68b)
Net Margin = 3.34% (Net Income TTM 423.0m / Revenue TTM 12.68b)
Gross Margin = 19.70% ((Revenue TTM 12.68b - Cost of Revenue TTM 10.19b) / Revenue TTM)
Gross Margin QoQ = 14.90% (prev 15.28%)
Tobins Q-Ratio = 0.40 (Enterprise Value 5.21b / Total Assets 13.18b)
Interest Expense / Debt = 1.13% (Interest Expense 54.0m / Debt 4.79b)
Taxrate = 35.67% (61.0m / 171.0m)
NOPAT = 595.7m (EBIT 926.0m * (1 - 35.67%))
Current Ratio = 1.35 (Total Current Assets 5.27b / Total Current Liabilities 3.91b)
Debt / Equity = 1.52 (Debt 4.79b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 1.44 (Net Debt 3.06b / EBITDA 2.13b)
Debt / FCF = 2.77 (Net Debt 3.06b / FCF TTM 1.10b)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.23% (Net Income 423.0m / Total Assets 13.18b)
RoE = 13.41% (Net Income TTM 423.0m / Total Stockholder Equity 3.15b)
RoCE = 15.06% (EBIT 926.0m / Capital Employed (Equity 3.15b + L.T.Debt 2.99b))
RoIC = 8.77% (NOPAT 595.7m / Invested Capital 6.79b)
WACC = 4.02% (E(2.15b)/V(6.94b) * Re(11.38%) + D(4.79b)/V(6.94b) * Rd(1.13%) * (1-Tc(0.36)))
Discount Rate = 11.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.11%
[DCF] Terminal Value 86.44% ; FCFF base≈1.06b ; Y1≈1.07b ; Y5≈1.16b
[DCF] Fair Price = 185.8 (EV 34.59b - Net Debt 3.06b = Equity 31.54b / Shares 169.8m; r=5.90% [WACC]; 5y FCF grow 0.69% → 2.90% )
EPS Correlation: -23.72 | EPS CAGR: 3.62% | SUE: 1.60 | # QB: 2
Revenue Correlation: -88.49 | Revenue CAGR: -5.87% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=7
EPS next Year (2027-03-31): EPS=3.27 | Chg7d=+0.130 | Chg30d=+0.124 | Revisions Net=+2 | Growth EPS=+3.0% | Growth Revenue=-2.4%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -7.3% (Discount Rate 11.4% - Earnings Yield 18.7%)
[Growth] Growth Spread = +5.4% (Analyst -1.9% - Implied -7.3%)
P/E Forward = 3.639
P/S = 0.1693
P/B = 0.658
P/EG = 0.28
Revenue TTM = 12.68b USD
EBIT TTM = 926.0m USD
EBITDA TTM = 2.13b USD
Long Term Debt = 2.99b USD (from longTermDebt, last quarter)
Short Term Debt = 765.0m USD (from shortTermDebt, last quarter)
Debt = 4.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.06b USD (from netDebt column, last quarter)
Enterprise Value = 5.21b USD (2.15b + Debt 4.79b - CCE 1.73b)
Interest Coverage Ratio = 4.23 (Ebit TTM 926.0m / Interest Expense TTM 219.0m)
EV/FCF = 4.71x (Enterprise Value 5.21b / FCF TTM 1.10b)
FCF Yield = 21.23% (FCF TTM 1.10b / Enterprise Value 5.21b)
FCF Margin = 8.71% (FCF TTM 1.10b / Revenue TTM 12.68b)
Net Margin = 3.34% (Net Income TTM 423.0m / Revenue TTM 12.68b)
Gross Margin = 19.70% ((Revenue TTM 12.68b - Cost of Revenue TTM 10.19b) / Revenue TTM)
Gross Margin QoQ = 14.90% (prev 15.28%)
Tobins Q-Ratio = 0.40 (Enterprise Value 5.21b / Total Assets 13.18b)
Interest Expense / Debt = 1.13% (Interest Expense 54.0m / Debt 4.79b)
Taxrate = 35.67% (61.0m / 171.0m)
NOPAT = 595.7m (EBIT 926.0m * (1 - 35.67%))
Current Ratio = 1.35 (Total Current Assets 5.27b / Total Current Liabilities 3.91b)
Debt / Equity = 1.52 (Debt 4.79b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 1.44 (Net Debt 3.06b / EBITDA 2.13b)
Debt / FCF = 2.77 (Net Debt 3.06b / FCF TTM 1.10b)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.23% (Net Income 423.0m / Total Assets 13.18b)
RoE = 13.41% (Net Income TTM 423.0m / Total Stockholder Equity 3.15b)
RoCE = 15.06% (EBIT 926.0m / Capital Employed (Equity 3.15b + L.T.Debt 2.99b))
RoIC = 8.77% (NOPAT 595.7m / Invested Capital 6.79b)
WACC = 4.02% (E(2.15b)/V(6.94b) * Re(11.38%) + D(4.79b)/V(6.94b) * Rd(1.13%) * (1-Tc(0.36)))
Discount Rate = 11.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.11%
[DCF] Terminal Value 86.44% ; FCFF base≈1.06b ; Y1≈1.07b ; Y5≈1.16b
[DCF] Fair Price = 185.8 (EV 34.59b - Net Debt 3.06b = Equity 31.54b / Shares 169.8m; r=5.90% [WACC]; 5y FCF grow 0.69% → 2.90% )
EPS Correlation: -23.72 | EPS CAGR: 3.62% | SUE: 1.60 | # QB: 2
Revenue Correlation: -88.49 | Revenue CAGR: -5.87% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-2 | Analysts=7
EPS next Year (2027-03-31): EPS=3.27 | Chg7d=+0.130 | Chg30d=+0.124 | Revisions Net=+2 | Growth EPS=+3.0% | Growth Revenue=-2.4%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -7.3% (Discount Rate 11.4% - Earnings Yield 18.7%)
[Growth] Growth Spread = +5.4% (Analyst -1.9% - Implied -7.3%)